- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to our digital archives and MarketGlass Research Platform
- Complimentary updates for one year
Edition: 9; Released: January 2022
Executive Pool: 373
Companies: 11 – Players covered include Certara LP; Chemical Computing Group ULC; Compugen Ltd.; Dassault Systemes; Genedata AG; Insilico Biotechnology AG; Leadscope, Inc.; Nimbus Therapeutics; Rosa & Co. LLC; Schrodinger LLC; Simulations Plus, Inc.; Strand Life Sciences Pvt., Ltd. and Others.
Coverage: All major geographies and key segments
Segments: Application Area (Cellular & Biological Simulation, Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software); End-Use (Academics, Industry, Commercial); Service (In-House Services, Contract Services)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Complimentary Project Preview – This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends;…
